Iron‐deficiency anemia is a potent stimulator of the phosphaturic hormone FGF23, and anemia, elevated FGF23, and serum phosphate are all significant risk factors for chronic kidney disease (CKD) patient death; however, the contribution of anemia to circulating FGF23 in CKD is not understood. This evidence concerns the gene FGF23 and chronic kidney disease.